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Abstract 
Purpose: To investigate the anti-urolithiatic activity of the aqueous and alcoholic extracts of Melia 
azedarach Linn leaves  in calcium oxalate urolithiasis in male albino rats.  
Methods: The effect of oral administration of aqueous and ethanol extracts of Melia azedarach Linn 
leaves on calcium oxalate urolithiasis has been investigated. Lithiasis was induced by oral adminstration 
of ethylene glycol (0.75 %v/v) in male albino rats for 28 days. Each of the extract (250 mg/kg) was 
administered orally day 0 as a prophylactic regimen and from day 15 as a curative regimen. Regular 
administration of ethylene glycol caused hyperoxaluria in ethylene glycol-fed animals, leading to 
increased renal retention and excretion of oxalate, calcium and phosphate. Histopathological study, 
urine microscopy, serum analysis and biochemical analysis of kidney homogenate were performed.  
Results: Oxalate and calcium excretion in urine increased (p < 0.01)  to 3.68 ± 0.01 and 4.5 ± 0.01 
mg/24 h, respectively, in lithiatic control animals compared to (0.37 ± 0.01 and 1.27 ± 0.12 mg/24 h) for 
the normal control group.  Treatment with aqueous or ethanol extract (250 mg/kg, p.o.) significantly (p < 
0.01) reduced the elevated levels of calcium, oxalate and phosphate excretion in urine to 0.79 ± 0.01 
and 1.09 ± 0.04 mg/24 h, respectively. Following treatment with the ethanol extract (250mg/kg), serum 
creatinine excretion was restored from 0.95 ± 0.01 mg/24 h to the normal level of 0.87 ± 0.01 mg/24 h. 
The results were comparable to those of the standard drug, allopurinol (50 mg/kg p.o.). 
Histopathological data for the kidney supported the foregoing results.  
Conclusions: The results demonstrate that the aqueous and ethanol extracts of Melia azedarach Linn 
leaves have potent antiurolithiatic activity against ethylene glycol-induced calcium oxalate urolithiasis in 
male albino rats. 
 
Keywords:  Melia azedarach, Antiurolithiatic, Ethylene glycol, Urolithiasis, Excretion, Kidney. 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Urinary calculi are the third prevalent disorder in 
the urinary system. It is calculated that nearly 
10% of the population of the industrialized world 
is affected by urinary tract stone disease. Kidney 
stones account for 0.5 to 1.9 % of clinical cases 
in industrialized countries [1]. Urinary calculi may 
cause obstruction, hydronephrosis, infection and 
hemorrhage in the urinary tract system [2]. Since 
the mid-1980s, management of nephrolithiasis 
has been by non-surgical methods such as 
lithotripsy, fiberoptic technology, electrical sparks 
and laser techniques, which provide therapeutic 
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alternatives to surgery.  Thus, the requirement 
for surgical intervention for removal of kidney 
stones has almost been reduced. Although, 
these procedures are cost-effective, they have 
side effects and may cause severe 
complications. Many Indian plants are thought to 
be useful antiurolithiatic agents [2,3]. Hence, 
plants are sometimes evaluated for possible 
antilithiatic. 
 
Melia azedarach Linn (meliaceae) popularly 
known as media dubia Cav, Indian lilac and 
Persian lilac, is found in most of the tropical and 
sub-tropical countries, including India, China, 
Japan .Philippines, Brazil, Argentina, as well as 
African and Arab countries, and the United 
States of America [4]. Chemical constituents of 
the leaves include nimbinene, quercetin-3-0-b-
rutinoside, kaempferol- 3-0-b rutinoside, rutin and 
kaempferol-3-L-rhamno-Dglucoside, nimbinene, 
azaridine , meliacin and quercetin [5,6]. A 
literature survey revealed that M. azedarach Linn 
also contains glycerol 1, 3-bisundec- 9- enoate 2-
dodec-9-enoate and glycerol tris-tridec-9-enoate, 
dipentadecyl ketone, flavonoids, limmonoids, 
tannis, sterols, saponines and triterpenoids which 
possibly contribute to its various uses in tradition 
medicine [7,8].  
 
The present investigation was designed to 
evaluate the anti-urolithiatic property of the 
aqueous and ethanol extract of Melia azedarach 
Linn leaves in ethylene glycol-induced calcium 




Collection of plant material  
 
The leaves of Melia azedarach were collected 
from the botanical garden at the Campus of 
Padmavathi College of Pharmacy, Dharmapuri in 
June, 2011. The plant was identified and 
authenticated by Dr. P. Jayaraman, Botanist, 
Director of Plant Anatomy Research Centre 
(PARC), Chennai, India. A voucher specimen 
(PARC /2011/2831) was deposited at the 
Padmavathi herbarium of the Centre for future 
reference.  
 
Preparation of aqueous extract  
 
The shade-dried leaves were pulverized to a 
coarse powder which was used for extraction. 
The aqueous extract was prepared according to 
a previous method [9]. Briefly, 100 g of the 
powdered leaves was mixed with 500 mL of 
distilled water in a 1 L flask and boiled for 11/2 h. 
The extract was filtered using whatman No.1 
filter paper after cooling it to 40°C. The filtrate 
was concentrated in a rotary evaporator under 
vacuum (40 °C) and stored at 4 °C until used. 
The yield was 8.23 %w/w. 
 
Preparation of ethanol extract 
 
Crude ethanolic extract of powered plants was 
prepared according to a previous method [10] in 
which 200 g of ground plant material was soaked 
in 500 ml of 70 % aqueous ethanol by cold 
maceration at room temperature for 72 h, after 
which the filtrate was collected through a piece of 
muslin cloth and then filter paper; the marc was 
subjected to the same procedure twice. The 
filtrate was concentrated in a rotary evaporator at 
40 °C under reduced pressure to yield the crude 
extract. This extract was stored at 4 °C pending 
its use. The yield of the extract was 8.84 %w/w. 
The aqueous and alcohol extracts were 
subjected to preliminary phytochemical analyses 
using standard methods [11]. 
 
 Experimental animals 
 
Male albino rats weighing 150 ‐ 200 g were used. 
The animals were fed standardized animal chow 
and water ad libitum. The rats were used after 
acclimatization under controlled conditions of 
temperature of 24 ± 2 °C, humidity of 50 ± 5 % 
and 10 - 12 h of light and dark cycles for one 
week. The animals were housed individually in 
metabolic cages containing sterile paddy husk as 
bedding throughout the experiment. The toxicity 
and anti-urolithic experimental studies were 
conducted after obtaining the approval of the 
institutional Animal Ethical Committee, 
Padmavathi College of Pharmacy (approval ref. 
no IECA/CBCSEA/2012/093). Animal experi-
ments were performed in accordance with the 
guide for the humane care and use of laboratory 
animals [11] and CPCSEA guidelines of the 
Government of India. 
 
Acute toxicity studies 
 
Male albino rats were used for studies. The 
animal were fasted overnight, providing them 
with only water. Acute oral toxicity study was 
performed using both the aqueous and ethanol 
extracts (based on OECD guidelines) at dose 
range 250 to 2500 mg/kg [12]. If mortality was 
observed in two out of three animals, than the 
dose administered was assigned as toxic dose. If 
the mortality was observed in one animal, than 
the same dose was repeated again, and if 
mortality was not observed, the procedure was 
repeated for the higher dose, up to 2500 mg/kg. 
The animals were observed for body 
temperature, behavioral, neurological and 
autonomic profiles for 24 h [13]. 
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Animal studies  
 
The animals were divided into seven groups of 6 
animals each. Group I served as normal control 
and received regular rat feed and drinking water 
ad libitum. Ethylene glycol (0.75 %) in drinking 
water was fed to Groups II ‐ VII for induction of 
renal calculi for 28 days. Group II served as 
lithiatic control and received vehicle (1% Tween 
80); Group III received the standard anti-
urolithiatic drug, allopurinol (50 mg/kg bw, po) 
from the 15th to 28th day. Group IV received the 
aqueous extract (250mg/kg bw, po.) from the 
15th day till 28th day and served as curative 
regimen (CR). Group V received the ethanolic 
extract (250mg/kg bw, po.) from 1st day till 28th 
day and served as CR. Group VI received the 
aqueous extract (250 mg/kg, p.o.) from the 15th 
to 28th day and served as preventive regimen 
(PR). Group VII received the ethanol extract (250 
mg/kg, p.o.) from the 1st to 28th day and also 
served as PR. All the drugs were given once 




The rats were kept separately in metabolic cages 
and 24h urine samples were collected on the 
28th day. A drop of concentrated hydrochloric 
acid was added to the urine prior to storage at 4 
°C, and then analysed for calcium and oxalate 
content by colorimetric procedure [14]   and for 
phosphorus content by molybdenum blue 
reaction [15]. The collected urine samples were 
centrifuged at 3000 rpm for 10 min. After 
centrifugation, the urine samples were examined 
under light microscope to ensure the frequency, 
shape and size of the calcium oxalate crystals 
 
Serum analysis  
 
At the end of the treatment period, the animals 
were sacrificed by cervical dislocation under 
anaesthetia and blood was collected from the 
retro-orbital puncture of animal. Serum was 
separated by centrifugation at 10,000 g for 10 
min analyzed for creatinine and urea nitrogen 
content using commercially available kits and 




Three animals in each group were sacrificed at 
the end of the final urine collection. The kidneys 
were washed, weighed and fixed rapidly with 10 
% neutralized formalin (pH7.4), embedded in 
paraffin, sliced 5 μm pieces; the slices were 
stained with hematoxylin and eosin and mounted 
in diphenyl xylene. Tissue slices were 
photographed using optical microscopy and the 
histopathological changes in kidney architecture 
observed [17]. 
 
Biochemical analysis of kidney homogenate  
 
Isolated kidneys were dried at 80 C in a hot air 
oven. A sample of 100 mg of the dried kidney 
was boiled in 10 ml of 1M hydrochloric acid for 
30 min and homogenized. The homogenate was 
centrifuged at 2000 g for 10 min and the 
supernatant separated. The supernatant was 
analysed for calcium and oxalate content by a 
colorimetric procedure [14]   as well as for 
phosphorus content in the kidney homogenate by  




The data obtained were expressed as mean ± 
SD and analysed for differences using one-way 
ANOVA followed by Dunnet multiple comparison 
test using Graph Pad Prism software (GraphPad 




The preliminary phytochemical study of Melia 
azedarach showed the presence of flavonoids 
and saponins in aqueous extract and alkaloids, 
carbohydrates, glycosides, saponins, steroids 
and triterpenoids in the ethanol extract of Melia 
azedarach leaves.  
 
Acute toxicity  
 
The extract showed neither mortality nor any 
visible clinical signs of general weakness in the 
animals. Hence, 2500 mg/kg was considered as 
LD50 cut-off value and 250 mg/kg (1/10 of 2500 
mg/kg) was taken as treatment dose based on 




Chronic administration of ethylene glycol (0.75 
%) in aqueous solution to the rats resulted in 
hyperoxaluria. Oxalate and calcium excretion in 
urine increased to 3.68 ± 0.01 and 4.50 ± 0.01 
mg/24h respectively in calculi-induced animals 
compared to normal control group (Table 1, 
Group II).  
However, administration of ethanol extract and 
aqueous extracts significantly (p < 0.01) reduced 
the elevated levels of calcium, oxalate, 
phosphate excretion in urine to 0.79 ± 0.01 and 
1.09 ± 0.04 mg/24h, respectively (Table 1, 
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Table 1: Urinary excretion of kidney stone-forming constituents in experimental rats treated with Melia azedarach 
extracts (n = 6) 
 
Group  Dose (mg/kg)  
Urine parameter (mg/24h, mean ± SEM)  
Oxalate  Calcium  Phosphate  
 I : Normal control Vehicle  0.37±0.01  1.266±0.12  3.64±0.01  
II : Lithiatic control Vehicle  3.68±0.01  4.50±0.01  7.28±0.01  
III : Allopurinol  50  0.53±0.02*  1.49±0.01*  3.80±0.01*  
IV : Ethanolic extract (CR)  250  0.89±0.01*  1.78±0.01*  4.05±0.03*  
V : Aqueous extract (CR) 250  1.29±0.01* 1.90±0.02  4.13±0.02*   
VI : Ethanolic extract (PR)  250  0.79±0.01*  1.68±0.02*  3.98±0.02*  
VII : Aqueous extract (PR)  250  1.09±0.04*   1.87±0.02*   4.21±0.01*   
    
* p < 0.01 (significant  compared to lithiatic control); ns = not significant  
 
Table 2: Kidney stone-forming constituents in rats treated with Melia azedarach extracts (n = 6) 
 
Group Dose  (mg/kg)  
Kidney parameter (mg/g)  (mean ± SEM)  
Oxalate  Calcium  Phosphate  
 I : Normal control Vehicle  1.44±0.02 ** 3.22±0.02**  2.34±0.03**  
II : Lithiatic control Vehicle  5.73±0.03 4.77±0.02  3.75±0.03  
III : Allopurinol  50  1.60±0.02** 3.39±0.02**  2.52±0.02**  
IV : Ethanolic extract (CR)  250  1.82±0.01** 3.69±0.02**  2.75±0.02**  
V : Aqueous extract (CR) 250  2.13±0.02 ** 4.12±0.01  2.91±0.02**   
VI : Ethanolic extract (PR)  250  1.76±0.01** 3.59±0.04**  2.67±0.01**  
VII : Aqueous extract (PR) 250  2.07±0.01 ** 3.94±0.05  2.85±0.02**   
  
** p < 0.01 (significant  compared to lithiatic control); ns = not significant
Table 3: Serum parameters of rats treated with Melia azedarach extracts (n = 6) 
 
Group  Dose  (mg/kg)  
Serum parameter (mean ± SEM) 
Blood urea 
nitrogen Creatinine  Uric acid 
I: Normal control Vehicle  37.08±0.45 0.76±0.02 1.49±0.02 
II : Lithiatic control Vehicle  49.66±1.16 0.95±0.01 3.64±0.02 
III : Allopurinol  50  39.58±1.10** 0.81±0.01** 1.71±0.01ns 
IV : Ethanolic extract (CR)  250  40.53±1.19** 0.84±0.01** 1.90±0.01** 
V : Aqueous extract (CR) 250  41.98±1.42** 0.91±0.01ns 2.12±0.01** 
VI : Ethanolic extract (PR)  250  40.63±0.78** 0.87±0.01** 1.90±0.01** 
VII : Aqueous extract (PR) 250  40.77±0.808** 0.91±0.01ns 2.03±0.04** 
** p < 0.01 (significant  compared to lithiatic control); ns = not significant 
  
Administration of ethylene glycol (0.75 %v/v) to 
male albino rats for 14 days forms renal calculi 
composed mainly of calcium oxalate (Group II). 
Deposition of the crystalline components in the 
homogenised renal tissue increased to 5.73 ± 
0.03 mg/gm in lithiatic control group (Table 2, 
Group II). Kidney homogenate results reveal that 
both ethanol and aqueous extracts at a dose of 
250 mg/kg significantly (p < 0.01) lowered the 
elevated levels of calcium, oxalate, phosphate 
excretion closer to normal (control) group values 
(Table 2, Groups IV - VII). 
 
The creatinine clearance of lithiatic control rats 
were decreased, but it was improved in standard 
drug and extract-treated groups. Serum analysis 
showed a significant increase (p < 0.01) in 
creatinine levels in lithiatic control rats when 
compared to normal rats (Group I). After 
treatment with ethanol extract, serum creatinine 
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levels were restored to the normal value of 0.87 
± 0.01 mg/dl (Table 3, Group VI). 
 
Urine microscopy analysis revealed frequency 
and size of calcium oxalate crystals is larger in 
the urine of lithiatic group animals (Fig 1B), when 
compared with control group (Fig 1A). On the 
other hand, the ethanol and aqueous extract-
treated groups showed significant reduction in 
frequency and size of calcium oxalate crystals 




Fig 1: Urine microscopy photographs  of aqueous and 
ethanol extract treated group.  (A) normal group 
(control, untreated); (B) lithiatic control (untreated) 
group; (C) allopurinol-treated group; (D) aqueous 
extract-treated group (curative regimen); (E) ethanol 
extract-treated group (curative regimen); (F) aqueous 
extract-treated group (preventive regimen); and (G) 
ethanol extract-treated group (preventive regimen). 
 
The histopathological study of the kidneys from 
the rats in the normal control group (Group 1), 
presented a normal appearance with normal 
glomeruli, proximal and distal convoluted tubules 
without any inflammatory changes, normal blood 
vessels and no calcium oxalate depositions 
(Figure. 2A). In lithiatic control, there was 
presence of small slender pointed calcium 
oxalate crystals in lumen of proximal convoluted 
tubule.  
 
Tubules were highly dilated and cystic tubules 
with sloughing of the tubular epithelial cells 
(Figure 2B). There were irregular calcium oxalate 
crystals in the lamina of the tubules which 
caused dilation of proximal tubules along with 
interstitial inflammation.  
 
The aqueous extract-treated animals showed few 
crystals as well as appearance of slight edema 
and dilation in tubules (Figure 2C). Similarly, in 
animals administered ethanol extract, no crystals 
were observed and apparently retained normal 
morphology, tubular epithelial cells and glomeruli 
as in control group (Figure 2D). However, very 
mild degeneration of cells and cyst formation 
were observed.  
 
 
Fig 2:  Kidney histopathology of photographs of 
aqueous and ethanol extract treated group.  (A) 
normal group (untreated) (B) lithiatic control 
(untreated) group (C) allopurinol-treated group; ( D) 
aqueous extract-treated group (curative regimen); (E) 
ethanol-extract treated group (curative regimen); ( F) 
aqueous extract treated group (preventive 





Increased urinary calcium is a factor favoring the 
nucleation and precipitation of calcium, oxalate 
or phosphate from urine and consequent crystal 
growth. It has been reported that 
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hyperabsorption of calcium is due to defective 
renal tubular reabsorption [16]. Stone formation 
in ethylene glycol-fed animals is caused by 
hyperoxaluria, which causes increased renal 
retention and excretion of oxalate [17]. 
 
Evidence from earlier studies indicate that 
methylene glycol is metabolized to oxalate [20].  
Enzymatic disturbances are causative factors of 
idiopathic hyperoxaluria, which causes increased 
renal retention and excretion of oxalate [18]. In 
this study, supplementation with ethanol extract 
of Melia azedarach, restored urinary phosphate 
level, thereby reducing the risk of stone formation 
and lower the levels of calcium as well as oxalate 
in urine.  
 
The extracts hastened the process of dissolving 
the preformed stones in curative regimen and 
prevention of new stone formation in urinary 
system on prophylactic treatment, may be due to 
mild diuretic effect and antioxidant activity mild 
diuretic effect and antioxidant activity [22]. 
 
Similar histopathological observations, earlier 
reported support, the presence of glomerular 
atrophy and deposition of crystals and attainment 
of normalcy of tubular epithelial cells and 
glomeruli when treated with plant extract [5].  
In lithiatic control rats (Group II), marked renal 
damage is evidenced by the elevated serum 
levels of creatinine, uric acid and blood urea 
nitrogen. The significant elevated serum levels of 
blood urea nitrogen, creatinine and uric acid in 
lithiatic control animals may be due to the 
obstruction of the outflow of the urine by stones 
in urinary system. However, ethanol and 
aqueous extractrestored the elevated serum 
levels of creatinine, uric acid and blood urea 
nitrogen, the markers previously reported which 
affirms the potent antiurolithiatic activity of the 
extracts [4]. These results indicate the presence 
of calcium oxalate crystal aggregation inhibitory 
constituent(s) in the plant that interfere with 
crystal growth and aggregation; this probably is a 
pointer to a possible therapeutic strategy for the 
prevention of recurrent stone disease.  
The plant Melia azedarach extract have been 
reported to possess anti-inflammatory [23]  and 
antimicrobial activities [24], and this may 
complement its beneficial effect in urolithiasis, as 
infection and inflammation are likely to be 




The findings of this study demonstrate that the 
aqueous and ethanol leaf extracts of Melia 
azedarach Linn possess potent antiurolithiatic 
activity against ethylene glycol-induced calcium 
oxalate urolithiasis in rats. The antiurolithiatic 
effects may be mediated possibly through a 
combination of calcium oxalate crystal inhibition, 
as well as via diuretic, antioxidant, renal epithelial 
cell protective, and hyper-magneseuric effects. 
Further investigation on its safety profile, anti-
oxidant activity and diuretic effect is essential to 
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